- Investing Ideas
- /
- Australian Biotech Breakthroughs
Australian Biotech Breakthroughs
Results
4
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
4 companies
Mesoblast
Market Cap: AU$3.7b
Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.
MSB
AU$2.73
7D
-0.4%
1Y
7.1%
Aroa Biosurgery
Market Cap: AU$265.7m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.76
7D
2.0%
1Y
-1.3%
PYC Therapeutics
Market Cap: AU$956.5m
A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.
PYC
AU$1.63
7D
-2.7%
1Y
35.4%
Paradigm Biopharmaceuticals
Market Cap: AU$147.8m
Engages in the research and development of therapeutic products for human use in Australia.
PAR
AU$0.34
7D
-4.2%
1Y
-20.7%